Stockreport

Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE

Annovis Bio, Inc.  (ANVS) 
PDF MALVERN, Pa., March 27, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering tr [Read more]